CJC-1295 DAC
An educational overview of CJC-1295 DAC, a growth hormone-releasing hormone (GHRH) analog investigated for prolonged growth hormone signaling, IGF-1 biology, endocrine function, and body composition research.
Peptide Class
GHRH AnalogCategory
Growth HormonePrimary Target
GHRH ReceptorResearch Interest
HighResearch Snapshot
Overview
CJC-1295 DAC is a synthetic GHRH analog studied for its ability to stimulate growth hormone release through the GHRH receptor. The DAC component, or Drug Affinity Complex, is researched for its effect on pharmacokinetic duration.
Researchers investigate CJC-1295 DAC in relation to growth hormone physiology, IGF-1 signaling, endocrine regulation, body composition, recovery biology, and healthy aging.
How It Works
CJC-1295 DAC binds to GHRH receptors and is studied for stimulating growth hormone release. The DAC modification is researched for extending circulation time compared with non-DAC versions.
Areas of Scientific Interest
Related Compounds
FAQ
What does DAC mean?
DAC stands for Drug Affinity Complex. It is researched for its effect on circulation time and pharmacokinetic duration.
How is CJC-1295 DAC different from CJC-1295 No DAC?
The DAC version is studied for longer duration, while the no-DAC version is researched separately for a different pharmacokinetic profile.
Does this page include dosage information?
No. Cloud Peptides does not provide dosage recommendations or administration guidance.
Research Use Only
This page summarizes publicly available scientific literature for educational purposes only.
Cloud Peptides does not provide medical advice, treatment recommendations, or dosage information.
All products are intended strictly for laboratory research purposes only and are not for human consumption.